Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Adding To Their Expert Team, Albert Labs Announces The Formation And Chairs Of Its Two Advisory Boards.

Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies May 25TH , 2021 - VANCOUVER, BRITISH COLUMBIA, Albert Labs,…

Continue ReadingAdding To Their Expert Team, Albert Labs Announces The Formation And Chairs Of Its Two Advisory Boards.